“Clinical Implications, Safety, Efficacy of Recombinant Human Granulocyte Colony-Stimulating Factors and Pegylated Equivalent”. Epidemiology, Biostatistics, and Public Health, vol. 10, no. 4, July 2022, https://doi.org/10.2427/8845.